Literature DB >> 12885402

Differential expression of sphingolipids in P-glycoprotein or multidrug resistance-related protein 1 expressing human neuroblastoma cell lines.

Anne-Jan Dijkhuis1, Jenny Douwes, Willem Kamps, Hannie Sietsma, Jan Willem Kok.   

Abstract

The sphingolipid composition and multidrug resistance status of three human neuroblastoma cell lines were established. SK-N-FI cells displayed high expression and functional (efflux) activity of P-glycoprotein, while multidrug resistance-related protein 1 was relatively abundant and most active in SK-N-AS cells. These two cell lines exhibited higher sphingolipid levels, compared to SK-N-DZ, which had the lowest activity of either ATP-binding cassette transporter protein. SK-N-DZ cells also differed in ganglioside composition with predominant expression of b-series gangliosides. In conclusion, these three neuroblastoma cell lines offer a good model system to study sphingolipid metabolism in relation to ATP-binding cassette transporter protein function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885402     DOI: 10.1016/s0014-5793(03)00721-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Efficient trafficking of MDR1/P-glycoprotein to apical canalicular plasma membranes in HepG2 cells requires PKA-RIIalpha anchoring and glucosylceramide.

Authors:  Kacper A Wojtal; Erik de Vries; Dick Hoekstra; Sven C D van Ijzendoorn
Journal:  Mol Biol Cell       Date:  2006-05-24       Impact factor: 4.138

2.  Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells.

Authors:  Alessandro Prinetti; Danilo Millimaggi; Sandra D'Ascenzo; Matilda Clarkson; Arianna Bettiga; Vanna Chigorno; Sandro Sonnino; Antonio Pavan; Vincenza Dolo
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

3.  Dual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified Neuroblastoma.

Authors:  Joshua Felgenhauer; Laura Tomino; Julia Selich-Anderson; Emily Bopp; Nilay Shah
Journal:  Neoplasia       Date:  2018-08-25       Impact factor: 5.715

Review 4.  Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance.

Authors:  Paola Giussani; Cristina Tringali; Laura Riboni; Paola Viani; Bruno Venerando
Journal:  Int J Mol Sci       Date:  2014-03-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.